BUSINESS COMBINATIONS - Disclosure of detailed information about cash outflow/inflow on the acquisition (Details) - Mar. 15, 2019 - Adjupharm GmbH ("Adjupharm") [Member] € in Thousands, $ in Thousands |
CAD ($) |
EUR (€) |
|---|---|---|
| Disclosure of detailed information about business combination [line items] | ||
| Cash and cash equivalents acquired with the acquiree at the acquisition date | $ 84 | |
| Cash paid | (1,400) | € (924) |
| Net cash outflow | $ (1,316) |
| X | ||||||||||
- Definition The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The fair value, at acquisition date, of net cash transferred as consideration in a business combination. No definition available.
|
| X | ||||||||||
- Details
|